The recent clinical experiments involving injection of plasmids into the myocardium, during surgical treatment or a mini-thoracotomy, are very interesting, but are unable to solve many problems when this procedure is used as the one and only therapy, in particular problems relating to optimization of the most suitable site for injection and the number and dosing of the intramyocardial injections.